Carbokem Novo 150mg Injection Substitute

Substitutes of Carbokem Novo 150mg Injection meet the same safety and efficacy standards as Carbokem Novo 150mg Injection, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Carbokem Novo 150mg Injection may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Carbokem Novo 150mg Injection if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Carbokem Novo 150mg Injection for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Carbokem Novo 150mg Injection is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Carbokem Novo 150mg Injection to its substitute. Always consult your doctor before switching.

Carbokem Novo 150mg Injection is used to treat ovarian cancer and small-cell lung cancer.

Carbokem Novo 150mg Injection contains 'Carboplatin'. Carboplatin works by breaching the cellular wall and binding to the cell’s DNA, preventing the cell from dividing and functioning normally, which eventually kills the cell.

Yes, Carbokem Novo 150mg Injection can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.

Carbokem Novo 150mg Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Before you receive treatment with Carbokem Novo 150mg Injection, tell your doctor about all of your medical conditions. You should not receive Carbokem Novo 150mg Injection if you are allergic to carboplatin or any contents in Carbokem Novo 150mg Injection. It should not be employed in patients with severe bone marrow depression or significant bleeding.

If not given an inappropriate dose, Carbokem Novo 150mg Injection can cause toxic effects, although not everyone gets it. So, Carbokem Novo 150mg Injection is prescribed by a doctor experienced in the use of medications to treat cancer only.

Avoid taking Carbokem Novo 150mg Injection if you are pregnant because Carbokem Novo 150mg Injection can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Carbokem Novo 150mg Injection.

Carbokem Novo 150mg Injection is administered to you through an intravenous (IV) infusion. A healthcare professional usually gives it in a medical facility.

Carbokem Novo 150mg Injection is not cell cycle specific. It works by forming DNA adducts, which leads to cell death. This mechanism of action is not specific to any particular phase of the cell cycle, meaning it can affect cells at various stages of their life cycle.

Yes, Carbokem Novo 150mg Injection is FDA approved. It was approved on 3 March 1989.

Yes, Carbokem Novo 150mg Injection is a platinum-containing compound medication that works by stopping or slowing the growth of cancer cells.

Carbokem Novo 150mg Injection may cause side effects, including neuropathy (tingling and numbness) in the hands and feet, hearing loss, temporary hair loss, and constipation. Weight gain is rare but possible. While leukemia is not typically associated with Carbokem Novo 150mg Injection, the long-term use of any chemotherapy drug can increase the risk of secondary cancers. It's important to discuss any side effects with your doctor to manage them effectively.

Carbokem Novo 150mg Injection is not a vesicant, and it does not cause blistering or tissue damage if it leaks out of the vein. It is also not cardio-toxic, so it does not specifically target the heart. Additionally, Carboplatin is not an anthracycline, as it does not belong to that class of platinum-containing compounds.

Yes, sometimes the doctor may suggest Carbokem Novo 150mg Injection to treat breast cancer based on your health situation. It is often given in combination with other chemotherapy drugs for optimal results.

Carbokem Novo 150mg Injection is not available in pill form; It is available in two primary dosage forms: injection and powder for injection.

The common side effects of the Carbokem Novo 150mg Injection are nausea, vomiting, diarrhoea, constipation, sores in the mouth and throat, pain, burning, or tingling in the hands or feet, pain, itching, redness, swelling, blisters, or sores in the place where the medication was injected, hair loss, pain, weakness, loss in ability to taste food. However, these symptoms vanish as your body adjusts to the medication. If these symptoms become worse, please consult a doctor for relief.

The efficacy and safety of Carbokem Novo 150mg Injection have yet to be established for using children. Please consult your doctor. The doctor will help determine whether the potential benefits outweigh the possible risks and make the appropriate recommendation.